nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CYP1A2—Carmustine—lymphatic system cancer	0.125	0.209	CbGbCtD
Acetaminophen—CYP2E1—Mitoxantrone—lymphatic system cancer	0.101	0.17	CbGbCtD
Acetaminophen—CYP2C9—Teniposide—lymphatic system cancer	0.0755	0.126	CbGbCtD
Acetaminophen—ABCB1—Mitoxantrone—lymphatic system cancer	0.0512	0.0857	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—lymphatic system cancer	0.0479	0.0802	CbGbCtD
Acetaminophen—CYP3A4—Cytarabine—lymphatic system cancer	0.0446	0.0746	CbGbCtD
Acetaminophen—CYP3A4—Teniposide—lymphatic system cancer	0.0439	0.0735	CbGbCtD
Acetaminophen—ABCB1—Vincristine—lymphatic system cancer	0.0353	0.059	CbGbCtD
Acetaminophen—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0307	0.0514	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—lymphatic system cancer	0.0213	0.0357	CbGbCtD
Acetaminophen—CYP3A4—Vincristine—lymphatic system cancer	0.0211	0.0354	CbGbCtD
Acetaminophen—Dyspnoea—Fludarabine—lymphatic system cancer	0.001	0.00248	CcSEcCtD
Acetaminophen—Oedema peripheral—Carmustine—lymphatic system cancer	0.000995	0.00247	CcSEcCtD
Acetaminophen—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000993	0.00247	CcSEcCtD
Acetaminophen—Dyspepsia—Fludarabine—lymphatic system cancer	0.000987	0.00245	CcSEcCtD
Acetaminophen—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.000985	0.00245	CcSEcCtD
Acetaminophen—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000976	0.00243	CcSEcCtD
Acetaminophen—Decreased appetite—Fludarabine—lymphatic system cancer	0.000975	0.00242	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000968	0.0024	CcSEcCtD
Acetaminophen—Fatigue—Fludarabine—lymphatic system cancer	0.000967	0.0024	CcSEcCtD
Acetaminophen—Hallucination—Vincristine—lymphatic system cancer	0.00096	0.00238	CcSEcCtD
Acetaminophen—Constipation—Fludarabine—lymphatic system cancer	0.000959	0.00238	CcSEcCtD
Acetaminophen—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000952	0.00237	CcSEcCtD
Acetaminophen—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000948	0.00235	CcSEcCtD
Acetaminophen—Urethral disorder—Vincristine—lymphatic system cancer	0.000945	0.00235	CcSEcCtD
Acetaminophen—Eye disorder—Carmustine—lymphatic system cancer	0.000944	0.00235	CcSEcCtD
Acetaminophen—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000944	0.00234	CcSEcCtD
Acetaminophen—Hypersensitivity—Teniposide—lymphatic system cancer	0.00094	0.00234	CcSEcCtD
Acetaminophen—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000939	0.00233	CcSEcCtD
Acetaminophen—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000939	0.00233	CcSEcCtD
Acetaminophen—Flushing—Carmustine—lymphatic system cancer	0.000938	0.00233	CcSEcCtD
Acetaminophen—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000935	0.00232	CcSEcCtD
Acetaminophen—Anaemia—Bleomycin—lymphatic system cancer	0.000931	0.00231	CcSEcCtD
Acetaminophen—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000924	0.0023	CcSEcCtD
Acetaminophen—Asthenia—Teniposide—lymphatic system cancer	0.000915	0.00227	CcSEcCtD
Acetaminophen—Malaise—Bleomycin—lymphatic system cancer	0.000909	0.00226	CcSEcCtD
Acetaminophen—Pruritus—Teniposide—lymphatic system cancer	0.000903	0.00224	CcSEcCtD
Acetaminophen—Leukopenia—Bleomycin—lymphatic system cancer	0.000902	0.00224	CcSEcCtD
Acetaminophen—Cardiac disorder—Vincristine—lymphatic system cancer	0.000895	0.00222	CcSEcCtD
Acetaminophen—Body temperature increased—Fludarabine—lymphatic system cancer	0.000887	0.0022	CcSEcCtD
Acetaminophen—Mental disorder—Carmustine—lymphatic system cancer	0.000885	0.0022	CcSEcCtD
Acetaminophen—Erythema—Carmustine—lymphatic system cancer	0.000879	0.00218	CcSEcCtD
Acetaminophen—Malnutrition—Carmustine—lymphatic system cancer	0.000879	0.00218	CcSEcCtD
Acetaminophen—Cough—Bleomycin—lymphatic system cancer	0.000879	0.00218	CcSEcCtD
Acetaminophen—Angiopathy—Vincristine—lymphatic system cancer	0.000875	0.00217	CcSEcCtD
Acetaminophen—Diarrhoea—Teniposide—lymphatic system cancer	0.000873	0.00217	CcSEcCtD
Acetaminophen—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000869	0.00216	CcSEcCtD
Acetaminophen—Chest pain—Bleomycin—lymphatic system cancer	0.000858	0.00213	CcSEcCtD
Acetaminophen—Coma—Methotrexate—lymphatic system cancer	0.000851	0.00211	CcSEcCtD
Acetaminophen—Discomfort—Bleomycin—lymphatic system cancer	0.000847	0.00211	CcSEcCtD
Acetaminophen—Mental disorder—Vincristine—lymphatic system cancer	0.000845	0.0021	CcSEcCtD
Acetaminophen—Chills—Mitoxantrone—lymphatic system cancer	0.000843	0.00209	CcSEcCtD
Acetaminophen—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000829	0.00206	CcSEcCtD
Acetaminophen—Confusional state—Bleomycin—lymphatic system cancer	0.000829	0.00206	CcSEcCtD
Acetaminophen—Vision blurred—Carmustine—lymphatic system cancer	0.000829	0.00206	CcSEcCtD
Acetaminophen—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000826	0.00205	CcSEcCtD
Acetaminophen—Tremor—Carmustine—lymphatic system cancer	0.000824	0.00205	CcSEcCtD
Acetaminophen—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000822	0.00204	CcSEcCtD
Acetaminophen—Oedema—Bleomycin—lymphatic system cancer	0.000822	0.00204	CcSEcCtD
Acetaminophen—Erythema—Mitoxantrone—lymphatic system cancer	0.000818	0.00203	CcSEcCtD
Acetaminophen—Anaemia—Carmustine—lymphatic system cancer	0.000813	0.00202	CcSEcCtD
Acetaminophen—Vomiting—Teniposide—lymphatic system cancer	0.000811	0.00202	CcSEcCtD
Acetaminophen—Agitation—Carmustine—lymphatic system cancer	0.000808	0.00201	CcSEcCtD
Acetaminophen—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000805	0.002	CcSEcCtD
Acetaminophen—Asthenia—Fludarabine—lymphatic system cancer	0.000805	0.002	CcSEcCtD
Acetaminophen—Rash—Teniposide—lymphatic system cancer	0.000805	0.002	CcSEcCtD
Acetaminophen—Dermatitis—Teniposide—lymphatic system cancer	0.000804	0.002	CcSEcCtD
Acetaminophen—Headache—Teniposide—lymphatic system cancer	0.000799	0.00199	CcSEcCtD
Acetaminophen—Pruritus—Fludarabine—lymphatic system cancer	0.000793	0.00197	CcSEcCtD
Acetaminophen—Leukopenia—Carmustine—lymphatic system cancer	0.000787	0.00196	CcSEcCtD
Acetaminophen—Anorexia—Bleomycin—lymphatic system cancer	0.000784	0.00195	CcSEcCtD
Acetaminophen—Anaemia—Vincristine—lymphatic system cancer	0.000776	0.00193	CcSEcCtD
Acetaminophen—Agitation—Vincristine—lymphatic system cancer	0.000771	0.00192	CcSEcCtD
Acetaminophen—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00077	0.00191	CcSEcCtD
Acetaminophen—Photosensitivity—Methotrexate—lymphatic system cancer	0.00077	0.00191	CcSEcCtD
Acetaminophen—Hypotension—Bleomycin—lymphatic system cancer	0.000768	0.00191	CcSEcCtD
Acetaminophen—Diarrhoea—Fludarabine—lymphatic system cancer	0.000767	0.00191	CcSEcCtD
Acetaminophen—Convulsion—Carmustine—lymphatic system cancer	0.000762	0.00189	CcSEcCtD
Acetaminophen—Hypertension—Carmustine—lymphatic system cancer	0.000759	0.00189	CcSEcCtD
Acetaminophen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000759	0.00188	CcSEcCtD
Acetaminophen—Nausea—Teniposide—lymphatic system cancer	0.000758	0.00188	CcSEcCtD
Acetaminophen—Anaemia—Mitoxantrone—lymphatic system cancer	0.000756	0.00188	CcSEcCtD
Acetaminophen—Hepatic failure—Methotrexate—lymphatic system cancer	0.000753	0.00187	CcSEcCtD
Acetaminophen—Leukopenia—Vincristine—lymphatic system cancer	0.000751	0.00187	CcSEcCtD
Acetaminophen—Chest pain—Carmustine—lymphatic system cancer	0.000749	0.00186	CcSEcCtD
Acetaminophen—Anxiety—Carmustine—lymphatic system cancer	0.000746	0.00185	CcSEcCtD
Acetaminophen—Malaise—Mitoxantrone—lymphatic system cancer	0.000737	0.00183	CcSEcCtD
Acetaminophen—Dyspnoea—Bleomycin—lymphatic system cancer	0.000733	0.00182	CcSEcCtD
Acetaminophen—Renal failure acute—Methotrexate—lymphatic system cancer	0.000733	0.00182	CcSEcCtD
Acetaminophen—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000732	0.00182	CcSEcCtD
Acetaminophen—Convulsion—Vincristine—lymphatic system cancer	0.000727	0.00181	CcSEcCtD
Acetaminophen—Hypertension—Vincristine—lymphatic system cancer	0.000725	0.0018	CcSEcCtD
Acetaminophen—Confusional state—Carmustine—lymphatic system cancer	0.000724	0.0018	CcSEcCtD
Acetaminophen—Oedema—Carmustine—lymphatic system cancer	0.000718	0.00178	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000717	0.00178	CcSEcCtD
Acetaminophen—Decreased appetite—Bleomycin—lymphatic system cancer	0.000715	0.00178	CcSEcCtD
Acetaminophen—Cough—Mitoxantrone—lymphatic system cancer	0.000713	0.00177	CcSEcCtD
Acetaminophen—Vomiting—Fludarabine—lymphatic system cancer	0.000713	0.00177	CcSEcCtD
Acetaminophen—Convulsion—Mitoxantrone—lymphatic system cancer	0.000708	0.00176	CcSEcCtD
Acetaminophen—Rash—Fludarabine—lymphatic system cancer	0.000707	0.00176	CcSEcCtD
Acetaminophen—Dermatitis—Fludarabine—lymphatic system cancer	0.000706	0.00175	CcSEcCtD
Acetaminophen—Hypertension—Mitoxantrone—lymphatic system cancer	0.000706	0.00175	CcSEcCtD
Acetaminophen—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000703	0.00175	CcSEcCtD
Acetaminophen—Headache—Fludarabine—lymphatic system cancer	0.000703	0.00175	CcSEcCtD
Acetaminophen—Tachycardia—Carmustine—lymphatic system cancer	0.0007	0.00174	CcSEcCtD
Acetaminophen—Chest pain—Mitoxantrone—lymphatic system cancer	0.000696	0.00173	CcSEcCtD
Acetaminophen—Anxiety—Mitoxantrone—lymphatic system cancer	0.000694	0.00172	CcSEcCtD
Acetaminophen—Discomfort—Mitoxantrone—lymphatic system cancer	0.000688	0.00171	CcSEcCtD
Acetaminophen—Oedema—Vincristine—lymphatic system cancer	0.000685	0.0017	CcSEcCtD
Acetaminophen—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000685	0.0017	CcSEcCtD
Acetaminophen—Anorexia—Carmustine—lymphatic system cancer	0.000684	0.0017	CcSEcCtD
Acetaminophen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000678	0.00168	CcSEcCtD
Acetaminophen—Confusional state—Mitoxantrone—lymphatic system cancer	0.000673	0.00167	CcSEcCtD
Acetaminophen—Nervous system disorder—Vincristine—lymphatic system cancer	0.000672	0.00167	CcSEcCtD
Acetaminophen—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000671	0.00167	CcSEcCtD
Acetaminophen—Hypotension—Carmustine—lymphatic system cancer	0.000671	0.00167	CcSEcCtD
Acetaminophen—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000667	0.00166	CcSEcCtD
Acetaminophen—Oedema—Mitoxantrone—lymphatic system cancer	0.000667	0.00166	CcSEcCtD
Acetaminophen—Nausea—Fludarabine—lymphatic system cancer	0.000666	0.00165	CcSEcCtD
Acetaminophen—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000662	0.00165	CcSEcCtD
Acetaminophen—Shock—Mitoxantrone—lymphatic system cancer	0.000656	0.00163	CcSEcCtD
Acetaminophen—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000653	0.00162	CcSEcCtD
Acetaminophen—Urticaria—Bleomycin—lymphatic system cancer	0.000653	0.00162	CcSEcCtD
Acetaminophen—Anorexia—Vincristine—lymphatic system cancer	0.000653	0.00162	CcSEcCtD
Acetaminophen—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000651	0.00162	CcSEcCtD
Acetaminophen—Body temperature increased—Bleomycin—lymphatic system cancer	0.00065	0.00161	CcSEcCtD
Acetaminophen—Insomnia—Carmustine—lymphatic system cancer	0.000649	0.00161	CcSEcCtD
Acetaminophen—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000648	0.00161	CcSEcCtD
Acetaminophen—Irritability—Methotrexate—lymphatic system cancer	0.000646	0.0016	CcSEcCtD
Acetaminophen—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000645	0.0016	CcSEcCtD
Acetaminophen—Hypotension—Vincristine—lymphatic system cancer	0.00064	0.00159	CcSEcCtD
Acetaminophen—Dyspnoea—Carmustine—lymphatic system cancer	0.00064	0.00159	CcSEcCtD
Acetaminophen—Somnolence—Carmustine—lymphatic system cancer	0.000638	0.00158	CcSEcCtD
Acetaminophen—Anorexia—Mitoxantrone—lymphatic system cancer	0.000636	0.00158	CcSEcCtD
Acetaminophen—Decreased appetite—Carmustine—lymphatic system cancer	0.000624	0.00155	CcSEcCtD
Acetaminophen—Hypotension—Mitoxantrone—lymphatic system cancer	0.000623	0.00155	CcSEcCtD
Acetaminophen—Insomnia—Vincristine—lymphatic system cancer	0.00062	0.00154	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00062	0.00154	CcSEcCtD
Acetaminophen—Constipation—Carmustine—lymphatic system cancer	0.000614	0.00152	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000609	0.00151	CcSEcCtD
Acetaminophen—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000606	0.0015	CcSEcCtD
Acetaminophen—Decreased appetite—Vincristine—lymphatic system cancer	0.000596	0.00148	CcSEcCtD
Acetaminophen—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000595	0.00148	CcSEcCtD
Acetaminophen—Somnolence—Mitoxantrone—lymphatic system cancer	0.000593	0.00147	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000591	0.00147	CcSEcCtD
Acetaminophen—Feeling abnormal—Carmustine—lymphatic system cancer	0.000591	0.00147	CcSEcCtD
Acetaminophen—Fatigue—Vincristine—lymphatic system cancer	0.000591	0.00147	CcSEcCtD
Acetaminophen—Asthenia—Bleomycin—lymphatic system cancer	0.00059	0.00147	CcSEcCtD
Acetaminophen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000587	0.00146	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000587	0.00146	CcSEcCtD
Acetaminophen—Constipation—Vincristine—lymphatic system cancer	0.000586	0.00146	CcSEcCtD
Acetaminophen—Asthma—Methotrexate—lymphatic system cancer	0.000585	0.00145	CcSEcCtD
Acetaminophen—Pruritus—Bleomycin—lymphatic system cancer	0.000582	0.00145	CcSEcCtD
Acetaminophen—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00058	0.00144	CcSEcCtD
Acetaminophen—Fatigue—Mitoxantrone—lymphatic system cancer	0.000575	0.00143	CcSEcCtD
Acetaminophen—Constipation—Mitoxantrone—lymphatic system cancer	0.000571	0.00142	CcSEcCtD
Acetaminophen—Abdominal pain—Carmustine—lymphatic system cancer	0.000567	0.00141	CcSEcCtD
Acetaminophen—Body temperature increased—Carmustine—lymphatic system cancer	0.000567	0.00141	CcSEcCtD
Acetaminophen—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00056	0.00139	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00056	0.00139	CcSEcCtD
Acetaminophen—Pancytopenia—Methotrexate—lymphatic system cancer	0.000555	0.00138	CcSEcCtD
Acetaminophen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00055	0.00137	CcSEcCtD
Acetaminophen—Neutropenia—Methotrexate—lymphatic system cancer	0.000547	0.00136	CcSEcCtD
Acetaminophen—Dysuria—Methotrexate—lymphatic system cancer	0.000547	0.00136	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000546	0.00136	CcSEcCtD
Acetaminophen—Abdominal pain—Vincristine—lymphatic system cancer	0.000542	0.00135	CcSEcCtD
Acetaminophen—Body temperature increased—Vincristine—lymphatic system cancer	0.000542	0.00135	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000534	0.00133	CcSEcCtD
Acetaminophen—Urticaria—Mitoxantrone—lymphatic system cancer	0.00053	0.00132	CcSEcCtD
Acetaminophen—Hypersensitivity—Carmustine—lymphatic system cancer	0.000529	0.00131	CcSEcCtD
Acetaminophen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000527	0.00131	CcSEcCtD
Acetaminophen—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000527	0.00131	CcSEcCtD
Acetaminophen—Vomiting—Bleomycin—lymphatic system cancer	0.000523	0.0013	CcSEcCtD
Acetaminophen—Drowsiness—Methotrexate—lymphatic system cancer	0.000521	0.00129	CcSEcCtD
Acetaminophen—Rash—Bleomycin—lymphatic system cancer	0.000518	0.00129	CcSEcCtD
Acetaminophen—Dermatitis—Bleomycin—lymphatic system cancer	0.000518	0.00129	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000517	0.00128	CcSEcCtD
Acetaminophen—Asthenia—Carmustine—lymphatic system cancer	0.000515	0.00128	CcSEcCtD
Acetaminophen—Hypersensitivity—Vincristine—lymphatic system cancer	0.000505	0.00125	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—lymphatic system cancer	0.0005	0.00124	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000493	0.00122	CcSEcCtD
Acetaminophen—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000492	0.00122	CcSEcCtD
Acetaminophen—Asthenia—Vincristine—lymphatic system cancer	0.000492	0.00122	CcSEcCtD
Acetaminophen—Diarrhoea—Carmustine—lymphatic system cancer	0.000491	0.00122	CcSEcCtD
Acetaminophen—Nausea—Bleomycin—lymphatic system cancer	0.000488	0.00121	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000486	0.00121	CcSEcCtD
Acetaminophen—Asthenia—Mitoxantrone—lymphatic system cancer	0.000479	0.00119	CcSEcCtD
Acetaminophen—Dizziness—Carmustine—lymphatic system cancer	0.000475	0.00118	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—lymphatic system cancer	0.00047	0.00117	CcSEcCtD
Acetaminophen—Diarrhoea—Vincristine—lymphatic system cancer	0.000469	0.00116	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—lymphatic system cancer	0.000468	0.00116	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—lymphatic system cancer	0.000468	0.00116	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000462	0.00115	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—lymphatic system cancer	0.000459	0.00114	CcSEcCtD
Acetaminophen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000457	0.00113	CcSEcCtD
Acetaminophen—Vomiting—Carmustine—lymphatic system cancer	0.000456	0.00113	CcSEcCtD
Acetaminophen—Dizziness—Vincristine—lymphatic system cancer	0.000453	0.00113	CcSEcCtD
Acetaminophen—Rash—Carmustine—lymphatic system cancer	0.000453	0.00112	CcSEcCtD
Acetaminophen—Dermatitis—Carmustine—lymphatic system cancer	0.000452	0.00112	CcSEcCtD
Acetaminophen—Headache—Carmustine—lymphatic system cancer	0.00045	0.00112	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000442	0.0011	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—lymphatic system cancer	0.000437	0.00109	CcSEcCtD
Acetaminophen—Vomiting—Vincristine—lymphatic system cancer	0.000436	0.00108	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000434	0.00108	CcSEcCtD
Acetaminophen—Rash—Vincristine—lymphatic system cancer	0.000432	0.00107	CcSEcCtD
Acetaminophen—Dermatitis—Vincristine—lymphatic system cancer	0.000432	0.00107	CcSEcCtD
Acetaminophen—Headache—Vincristine—lymphatic system cancer	0.000429	0.00107	CcSEcCtD
Acetaminophen—Nausea—Carmustine—lymphatic system cancer	0.000426	0.00106	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—lymphatic system cancer	0.000425	0.00105	CcSEcCtD
Acetaminophen—Vomiting—Mitoxantrone—lymphatic system cancer	0.000424	0.00105	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—lymphatic system cancer	0.000423	0.00105	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000422	0.00105	CcSEcCtD
Acetaminophen—Rash—Mitoxantrone—lymphatic system cancer	0.000421	0.00105	CcSEcCtD
Acetaminophen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00042	0.00104	CcSEcCtD
Acetaminophen—Chills—Methotrexate—lymphatic system cancer	0.00042	0.00104	CcSEcCtD
Acetaminophen—Headache—Mitoxantrone—lymphatic system cancer	0.000418	0.00104	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—lymphatic system cancer	0.00041	0.00102	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—lymphatic system cancer	0.000407	0.00101	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—lymphatic system cancer	0.000407	0.00101	CcSEcCtD
Acetaminophen—Nausea—Vincristine—lymphatic system cancer	0.000407	0.00101	CcSEcCtD
Acetaminophen—Nausea—Mitoxantrone—lymphatic system cancer	0.000396	0.000985	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—lymphatic system cancer	0.000384	0.000954	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000378	0.000939	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—lymphatic system cancer	0.000376	0.000935	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—lymphatic system cancer	0.000367	0.000912	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—lymphatic system cancer	0.000365	0.000906	CcSEcCtD
Acetaminophen—Cough—Methotrexate—lymphatic system cancer	0.000355	0.000883	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—lymphatic system cancer	0.000353	0.000877	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—lymphatic system cancer	0.000347	0.000861	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000344	0.000855	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—lymphatic system cancer	0.000343	0.000851	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—lymphatic system cancer	0.000335	0.000833	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000332	0.000826	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000326	0.00081	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000325	0.000809	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—lymphatic system cancer	0.000323	0.000802	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000321	0.000798	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—lymphatic system cancer	0.000317	0.000787	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—lymphatic system cancer	0.000311	0.000772	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—lymphatic system cancer	0.000301	0.000747	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—lymphatic system cancer	0.000296	0.000736	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—lymphatic system cancer	0.000296	0.000734	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000293	0.000727	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—lymphatic system cancer	0.000289	0.000718	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000287	0.000713	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—lymphatic system cancer	0.000287	0.000712	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000274	0.000681	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000272	0.000675	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—lymphatic system cancer	0.000264	0.000656	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000263	0.000653	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—lymphatic system cancer	0.000263	0.000653	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000245	0.000608	CcSEcCtD
Acetaminophen—Asthenia—Methotrexate—lymphatic system cancer	0.000239	0.000592	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—lymphatic system cancer	0.000235	0.000584	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—lymphatic system cancer	0.000227	0.000565	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—lymphatic system cancer	0.00022	0.000546	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—lymphatic system cancer	0.000211	0.000525	CcSEcCtD
Acetaminophen—Rash—Methotrexate—lymphatic system cancer	0.00021	0.000521	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—lymphatic system cancer	0.000209	0.00052	CcSEcCtD
Acetaminophen—Headache—Methotrexate—lymphatic system cancer	0.000208	0.000517	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—lymphatic system cancer	0.000197	0.000491	CcSEcCtD
